Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1B2P8 is a processed pseudogene related to the parental eukaryotic translation elongation factor 1 beta 2 (EEF1B2) gene[2][3]. The EEF1B2 protein is a component of the eEF1H complex, which is involved in the elongation step of protein synthesis. EEF1B2 pseudogenes, such as EEF1B2P8, result from retrotransposition events and typically do not encode functional proteins[2]. These pseudogenes have little or no known biological activity, drug interaction, or direct disease relevance[6][1]. While certain pseudogenes may be transcribed or even translated into peptides, EEF1B2P8 has not been characterized as doing so, nor is it recognized as a therapeutic or biomarker target[2][3][1]. EEF1B2P8 is a human processed pseudogene derived from the parental EEF1B2 gene. While EEF1B2 encodes a translation elongation factor involved in protein biosynthesis, EEF1B2P8 does not encode a functional protein, is not categorized as a therapeutic target, and lacks clinical or biological utility in the context of disease roles or drug interactions[1][3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 beta 2 pseudogene 8 (EEF1B2P8).